Ilico Genetics
Bethlehem
About Ilico Genetics
Developing a liquid biopsy test for the early-detection of stomach cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Convertible Note (Nov 2024)
- Website: ilicogenetics.com
- Phone: 6108495039
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ilico-genetics-56955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.